| Literature DB >> 29063039 |
Dong-Chao Shen1, Shuo-Lin Wu2,3,4,5, Yu-Zhi Shi2,3,4, Shuo Wang1,5, Yu-Mei Zhang2,3,4,6, Chun-Xue Wang2,3,4,5,6.
Abstract
OBJECTIVE: The presence of an association between white matter hyperintensity (WMH) and the risk of falls in older people is uncertain, with little supporting prospective evidence available at present. We aimed to determine whether WMH was associated with dysfunctions of balance and gait, and other sensorimotor factors leading to falls, and the independent factors related to falls in older Chinese people. The protective effect of exercise against falls was also addressed.Entities:
Keywords: Balance disorder; Fall risk; Gait disorder; White matter hyperintensity
Year: 2016 PMID: 29063039 PMCID: PMC5643759 DOI: 10.1016/j.cdtm.2016.11.008
Source DB: PubMed Journal: Chronic Dis Transl Med ISSN: 2095-882X
Characteristics of 101 participants with Fazekas grades 0–3.
| Items | WMH-Fazekas grade ( | ||||
|---|---|---|---|---|---|
| Grade 0 ( | Grade 1 ( | Grade 2 ( | Grade 3 ( | ||
| Age, years | 54.7 ± 10.2 | 60.9 ± 10.2 | 64.0 ± 11.6 | 67.4 ± 14.2 | 0.004 |
| Female, | 5 (23.8) | 12 (35.3) | 11 (47.8) | 8 (34.8) | 0.427 |
| Living alone, | 0 | 1 (2.9) | 3 (13) | 0 | 0.137 |
| Height, cm | 167.8 ± 7.4 | 167.4 ± 7.8 | 166.7 ± 8.8 | 165.7 ± 8.2 | 0.823 |
| Weight, kg | 74.9 ± 10.3 | 67.6 ± 8.2 | 66.8 ± 11.5 | 67.7 ± 11.3 | 0.034 |
| BMI, kg/m2 | 26.5 ± 2.8 | 24.6 ± 2.4 | 24.0 ± 3.8 | 24.6 ± 3.1 | 0.037 |
| Overweight or obesity, | 17 (81.0) | 22 (64.7) | 8 (34.8) | 9 (39.1) | 0.004 |
| History of falls, | 3 (14.3) | 3 (8.8) | 6 (26.1) | 7 (30.4) | 0.139 |
| Physical active, | 9 (42.9) | 17 (50) | 12 (52.2) | 5 (21.7) | 0.126 |
| Ever-smoking, | 12 (57.1) | 16 (47.1) | 9 (39.1) | 13 (56.5) | 0.569 |
| Ever-drinking, | 7 (33.3) | 14 (41.2) | 8 (34.8) | 9 (39.1) | 0.930 |
| Hypertension, | 14 (66.7) | 20 (58.8) | 15 (65.2) | 16 (69.6) | 0.854 |
| Diabetes, | 8 (38.1) | 15 (44.1) | 11 (47.8) | 8 (34.8) | 0.801 |
| Hypercholesterolemia, | 12 (57.1) | 20 (58.8) | 14 (60.9) | 13 (56.5) | 0.991 |
| Ischemic stroke, | 13 (61.9) | 22 (64.7) | 11 (47.8) | 22 (95.7) | 0.005 |
| Coronary artery disease, | 3 (14.3) | 6 (17.6) | 2 (8.7) | 5 (21.7) | 0.659 |
| Antiplatelet drugs, | 14 (66.7) | 18 (52.9) | 11 (47.8) | 18 (78.3) | 0.126 |
| Antihypertensive drugs, | 9 (42.9) | 11 (32.4) | 7 (30.4) | 11 (47.8) | 0.537 |
| Hypoglycemic drugs, | 1 (4.8) | 7 (20.6) | 5 (21.7) | 5 (21.7) | 0.376 |
| Lipid-lowering drugs, | 14 (66.7) | 17 (50) | 13 (56.5) | 14 (60.9) | 0.655 |
| Sedative-hypnotics, | 3 (14.3) | 5 (14.7) | 5 (21.7) | 2 (8.7) | 0.669 |
| Kinds of drugs, | 2.6 ± 1.3 | 2.2 ± 1.8 | 2.5 ± 1.9 | 3.2 ± 2.0 | 0.192 |
| MoCA, scores | 24.3 ± 2.2 | 23.0 ± 4.0 | 20.5 ± 4.4 | 16.1 ± 5.7 | 0.000 |
| BBS-9, scores | 34.9 ± 1.7 | 34.7 ± 1.8 | 34.2 ± 2.1 | 31.9 ± 4.2 | 0.000 |
| TUGT, s | 8.3 ± 2.2 | 10.3 ± 3.1 | 11.3 ± 3.2 | 14.3 ± 4.3 | 0.000 |
| SOT, scores | 76.0 ± 7.9 | 73.0 ± 5.0 | 69.0 ± 6.0 | 62.4 ± 6.8 | 0.000 |
| MCT, ms | 143.3 ± 15.4 | 147.9 ± 10.2 | 151.2 ± 8.9 | 166.1 ± 21.9 | 0.000 |
| Falls during follow-up, | 1 (4.8) | 1 (2.9) | 4 (17.4) | 6 (26.1) | 0.030 |
Values are presented as mean ± standard deviation, n or n (%).
WMH: white matter hyperintensity; BMI: body mass index; MoCA: Montreal Cognitive Assessment; BBS-9: 9-item Berg Balance Scale; TUGT: timed-up-and-go test; SOT: sensory organization test; MCT: motor control test.
WMH and risk of falls.
| Items | WMH-Fazekas grade ( | ||||
|---|---|---|---|---|---|
| Grade 0 ( | Grade 1 ( | Grade 2 ( | Grade 3 ( | ||
| Fall | |||||
| | 1 (4.8) | 1 (2.9) | 3 (13.0) | 6 (26.1) | 0.030 |
| Crude model, | 1 | 0.14 (0.02–1.30) | 0.42 (0.10–1.77) | 0.60 (0.14–2.48) | |
| Adjusted model, | 1 | 0.34 (0.01–5.37) | 0.35 (0.02–6.47) | 0.14 (0.01–3.72) | |
| BBS-9 score ≤ 32 | |||||
| | 4 (19) | 5 (14.7) | 6 (26.1) | 12 (52.2) | 0.013 |
| Crude model, | 1 | 0.73 (0.17–3.11) | 1.50 (0.36–6.29) | 4.64 (1.19–18.11) | |
| Adjusted model, | 1 | 0.75 (0.08–6.89) | 0.84 (0.09–8.02) | 1.29 (0.17–9.58) | |
| TUGT ≥ 12.3 s | |||||
| | 3 (14.3) | 7 (20.6) | 5 (21.7) | 13 (56.5) | 0.005 |
| Crude model, | 1 | 1.56 (0.35–8.03) | 1.67 (0.35–8.04) | 7.80 (1.79–34.07) | |
| Adjusted model, | 1 | 0.98 (0.10–9.85) | 0.53 (0.05–5.48) | 3.32 (0.40–27.38) | |
| Abnormal SOT score | |||||
| | 3 (14.3) | 5 (14.7) | 8 (34.8) | 12 (52.2) | 0.007 |
| Crude model, | 1 | 1.03 (0.22–4.86) | 3.20 (0.72–14.25) | 6.55 (1.50–28.49) | |
| Adjusted model, | 1 | 0.44 (0.06–3.18) | 2.45 (0.36–16.77) | 5.38 (0.89–32.51) | |
| Abnormal MCT score | |||||
| | 7 (33.3) | 15 (44.1) | 13 (56.5) | 17 (73.9) | 0.039 |
| Crude model, | 1 | 1.58 (0.51–4.90) | 2.60 (0.76–8.86) | 5.67 (1.55–20.79) | |
| Adjusted model, | 1 | 1.25 (0.32–4.92) | 1.88 (0.41–8.70) | 5.01 (1.12–22.44) | |
WMH: white matter hyperintensity; OR: odds ratio; CI: confidence interval; BBS-9: 9-item Berg Balance Scale; TUGT: timed-up-and-go test; SOT: sensory organization test; MCT: motor control test.
In univariate regression analysis, a significant association of pathologic gait and balance testing could be observed for the conditions of grade 3 vs. grade 0 WMH.
Adjusted for age, gender, living status, smoking, drinking, hypertension, hypercholesterolemia, diabetes, ischemic stroke, coronary artery disease, medications, physical activity and MoCA scores. Only the difference regarding MCT remained significant for the categories of grade 3 vs. grade 0 WMH in multivariate Logistic regression.
Risk factors for falls in univariate regression analysis.
| Risk factors | Non-fallers ( | Fallers ( | |
|---|---|---|---|
| Age, years | 60.9 ± 12.3 | 68.7 ± 9.0 | 0.037a |
| Female, | 28 (31.5) | 8 (66.7) | 0.039a |
| Living alone, | 3 (3.4) | 1 (8.3) | 0.402 |
| Height, cm | 167.6 ± 7.6 | 162.4 ± 9.7 | 0.035a |
| Weight, kg | 69.8 ± 10.5 | 62.5 ± 8.2 | 0.022a |
| BMI, kg/m2 | 25.0 ± 3.2 | 23.6 ± 1.8 | 0.146 |
| Overweight or obesity, | 53 (59.6) | 3 (25.0) | 0.024a |
| History of falls, | 13 (14.6) | 6 (50.0) | 0.011a |
| Physical active, | 41 (46.1) | 2 (16.7) | 0.053a |
| Ever-smoking, | 46 (51.7) | 4 (33.3) | 0.233 |
| Ever-drinking, | 35 (39.3) | 3 (25.0) | 0.519 |
| Hypertension, | 59 (66.3) | 6 (50.0) | 0.269 |
| Diabetes, | 37 (41.6) | 5 (41.7) | 0.995 |
| Hypercholesterolemia, | 53 (59.6) | 6 (50.0) | 0.269 |
| Ischemic stroke, | 59 (66.3) | 9 (75.0) | 0.783 |
| Coronary artery disease, | 15 (16.9) | 1 (8.3) | 0.416 |
| Antiplatelet drugs, | 54 (60.7) | 7 (58.3) | 1.000 |
| Antihypertensive drugs, | 34 (38.2) | 4 (33.3) | 0.992 |
| Hypoglycemic drugs, | 15 (16.9) | 3 (25.0) | 0.772 |
| Lipid-lowering drugs, | 51 (57.3) | 7 (58.3) | 0.946 |
| Kinds of drugs | 2.5 ± 1.8 | 2.8 ± 2.3 | 0.576 |
| WMH-Fazekas, | 0.030a | ||
| Grade 0 | 20 (22.5) | 1 (8.3) | |
| Grade 1 | 33 (37.1) | 1 (8.3) | |
| Grade 2 | 19 (21.3) | 4 (33.3) | |
| Grade 3 | 17 (20.3) | 6 (50.0) | |
| MoCA, scores | 21.7 ± 4.6 | 17.3 ± 7.2 | 0.005a |
| BBS-9, scores | 34.2 ± 2.8 | 32.3 ± 2.2 | 0.023a |
| TUGT, s | 10.6 ± 3.6 | 14.3 ± 4.0 | 0.001a |
| SOT, scores | 70.8 ± 8.1 | 66.5 ± 5.5 | 0.078a |
| MCT, ms | 150.5 ± 15.9 | 161.6 ± 18.1 | 0.028a |
Values are presented as mean ± standard deviation or n (%). aP < 0.1.
BMI: body mass index; WMH: white matter hyperintensity; MoCA: Montreal Cognitive Assessment; BBS-9: 9-item Berg Balance Scale: TUGT: timed-up-and-go test; SOT: sensory organization test; MCT: motor control test.
Risk factors for falls in multiple regression analysis.
| Risk factors | ||
|---|---|---|
| Female | 4.21 (1.02–17.40) | 0.047 |
| History of falls | 4.84 (1.15–20.46) | 0.032 |
| TUGT | 1.18 (1.03–1.40) | 0.046 |
OR: odds ratio; CI: confidence interval; TUGT: timed-up-and-go test.